Suppr超能文献

用异戊巴比妥钠替代无菌水作为 SIR-Spheres 输送介质:改善剂量传递和降低淤滞发生率。

Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis.

机构信息

From the Division of Interventional Radiology, University of Pennsylvania, Philadelphia, PA.

出版信息

Clin Nucl Med. 2017 Mar;42(3):176-179. doi: 10.1097/RLU.0000000000001532.

Abstract

PURPOSE

The objective of this study was to evaluate the effect of substituting 50% Isovue (Bracco Diagnostics Inc, Monroe Township, NJ) for sterile water on the delivery of Y resin microspheres (SIR-Spheres [Sirtex Medical Limited, Sydney, Australia]).

MATERIALS AND METHODS

The authors retrospectively reviewed all SIR-Spheres radioembolizations at the authors' institution from January 1, 2011, to February 10, 2014. From January 1, 2011, to April 30, 2013, all users performed SIR-Spheres radioembolization per the manufacturer's original instructions using sterile water in the B and D lines and intermittently checking the progress of the embolization by injecting contrast via the B line. Beginning May 1, 2013, a modified technique using Isovue diluted 50% with saline in place of sterile water in both the B and D lines of the infusion set. The authors compared the prepared versus administered activity of Y SIR-Spheres, fluoroscopy time, administration time, and frequency of radioembolizations terminated for stasis when using water versus dilute contrast in the B and D lines.

RESULTS

One hundred seventy-five radioembolizations were performed, 132 (75%) with water as the delivery medium and 43 (25%) with 50% contrast as delivery medium. The mean percentage of the Y activity administered was 98% with contrast versus 87% with water (P < 0.01). More than 95% of cases using contrast resulted in 90% or more delivery of the prepared Y activity versus 59% of cases with water (P < 0.01). For cases using water, 17% were terminated for stasis, whereas 2% (1 case) using contrast was terminated for stasis. The mean Y administration time was 7 minutes with contrast versus 22 minutes with water (P = 0.015). Excluding the 37 cases involving coil embolization, the mean fluoroscopy time was 8.3 minutes with contrast versus 11.5 minutes with water (P < 0.05). No complications occurred with the contrast method; however, there were 4 complications with water, including 1 nontarget gastric ulceration.

CONCLUSIONS

Using dilute contrast as the delivery medium for SIR-Spheres resulted in a significantly greater percentage of the prepared activity administered to the patient with substantially shorter administration time. Termination for stasis occurred less often with dilute contrast. No complications were observed when using dilute contrast, which allowed continuous real-time monitoring of the Y microsphere administration.

摘要

目的

本研究旨在评估用 50%浓度的优维显(Bracco Diagnostics Inc,新泽西州门罗镇)替代无菌水对 Y 树脂微球(SIR-Spheres [Sirtex Medical Limited,澳大利亚悉尼])输送的影响。

材料与方法

作者回顾性分析了 2011 年 1 月 1 日至 2014 年 2 月 10 日期间在作者所在机构进行的所有 SIR-Spheres 放射性栓塞术。从 2011 年 1 月 1 日至 2013 年 4 月 30 日,所有用户均按照制造商的原始说明,使用无菌水在 B 和 D 线进行 SIR-Spheres 放射性栓塞术,并通过在 B 线注入造影剂间歇性检查栓塞的进展情况。从 2013 年 5 月 1 日开始,使用 50%浓度的优维显稀释液替代 B 和 D 线输液装置中的无菌水。作者比较了使用水和稀对比剂作为 B 和 D 线输送介质时,Y 型 SIR-Spheres 的制备与实际给予的放射性活度、透视时间、给药时间以及因血流停滞而终止栓塞的频率。

结果

共进行了 175 次放射性栓塞术,其中 132 次(75%)使用水作为输送介质,43 次(25%)使用 50%浓度的对比剂作为输送介质。使用对比剂时给予的 Y 放射性活度的平均百分比为 98%,而用水时为 87%(P<0.01)。使用对比剂的病例中,超过 95%的病例给予了 90%或更多的制备 Y 放射性活度,而用水时为 59%(P<0.01)。对于使用水的病例,有 17%因血流停滞而终止,而使用对比剂的病例中只有 2%(1 例)因血流停滞而终止。使用对比剂时,Y 型放射性活度的平均给药时间为 7 分钟,而用水时为 22 分钟(P=0.015)。排除涉及线圈栓塞的 37 例病例后,使用对比剂时的透视时间平均为 8.3 分钟,而用水时为 11.5 分钟(P<0.05)。对比剂法未发生任何并发症,但用水时发生了 4 例并发症,包括 1 例非目标性胃溃疡。

结论

使用稀对比剂作为 SIR-Spheres 的输送介质,可显著增加给予患者的制备放射性活度百分比,且给药时间明显缩短。使用稀对比剂时,因血流停滞而终止的情况较少发生。使用稀对比剂未观察到任何并发症,可实现 Y 型微球给药的实时连续监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验